Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Brophy

Showing results (141-150 of 245) with videos related to

Pageof 25
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 27, 2018
Response by Labos et al to Letter Regarding Article, "Evaluation of the Pleiotropic Effects of Statins: A Reanalysis of the Randomized Trial Evidence Using Egger Regression"Christopher Labos, James M Brophy, George Davey Smith, et al.
Pharmacoepidemiology and Drug Safety|July 22, 2009
Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysisKristian B Filion, Lawrence Joseph, Jean-François Boivin, et al.
Pharmacotherapy|January 14, 2015
Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic studyMahyar Etminan, Sean C Skeldon, Sheldon Larry Goldenberg, et al.
Scientific Reports|September 23, 2023
SGLT-2 inhibitors improve cardiovascular and renal outcomes in patients with CKD: a systematic review and meta-analysisThomas A Mavrakanas, Michael A Tsoukas, James M Brophy, et al.
Journal of Comparative Effectiveness Research|September 28, 2022
Developing a cross-validation tool for evaluating economic evidence in rapid literature reviewsXuanqian Xie, Chunmei Li, Sean Tiggelaar, et al.
The Canadian Journal of Cardiology|May 5, 2015
Screening Strategies and Primary Prevention Interventions in Relatives of People With Coronary Artery Disease: A Systematic Review and Meta-analysisMichael Goldfarb, Douglas Slobod, Line Dufresne, et al.
Pharmacoepidemiology and Drug Safety|June 15, 2011
Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitusKristian B Filion, Lawrence Joseph, Jean-François Boivin, et al.
Journal of the American College of Cardiology|July 1, 2017
Differences Between Conditional and Marginal Propensity Score Estimates: A Real-World ApplicationMichelle Samuel, Tibor Schuster, Jay S Kaufman, et al.
JAMA Dermatology|February 22, 2013
Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished dataMahyar Etminan, Steven T Bird, Joseph A Delaney, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 11, 2017
Evaluation of the Pleiotropic Effects of Statins: A Reanalysis of the Randomized Trial Evidence Using Egger Regression-Brief ReportChristopher Labos, James M Brophy, George Davey Smith, et al.
Pageof 25

Showing results (141-150 of 245) with videos related to

Sort By:
Pageof 25
Arteriosclerosis, Thrombosis, and Vascular Biology|April 27, 2018
Response by Labos et al to Letter Regarding Article, "Evaluation of the Pleiotropic Effects of Statins: A Reanalysis of the Randomized Trial Evidence Using Egger Regression"Christopher Labos, James M Brophy, George Davey Smith, et al.
Pharmacoepidemiology and Drug Safety|July 22, 2009
Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysisKristian B Filion, Lawrence Joseph, Jean-François Boivin, et al.
Pharmacotherapy|January 14, 2015
Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic studyMahyar Etminan, Sean C Skeldon, Sheldon Larry Goldenberg, et al.
Scientific Reports|September 23, 2023
SGLT-2 inhibitors improve cardiovascular and renal outcomes in patients with CKD: a systematic review and meta-analysisThomas A Mavrakanas, Michael A Tsoukas, James M Brophy, et al.
Journal of Comparative Effectiveness Research|September 28, 2022
Developing a cross-validation tool for evaluating economic evidence in rapid literature reviewsXuanqian Xie, Chunmei Li, Sean Tiggelaar, et al.
The Canadian Journal of Cardiology|May 5, 2015
Screening Strategies and Primary Prevention Interventions in Relatives of People With Coronary Artery Disease: A Systematic Review and Meta-analysisMichael Goldfarb, Douglas Slobod, Line Dufresne, et al.
Pharmacoepidemiology and Drug Safety|June 15, 2011
Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitusKristian B Filion, Lawrence Joseph, Jean-François Boivin, et al.
Journal of the American College of Cardiology|July 1, 2017
Differences Between Conditional and Marginal Propensity Score Estimates: A Real-World ApplicationMichelle Samuel, Tibor Schuster, Jay S Kaufman, et al.
JAMA Dermatology|February 22, 2013
Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished dataMahyar Etminan, Steven T Bird, Joseph A Delaney, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 11, 2017
Evaluation of the Pleiotropic Effects of Statins: A Reanalysis of the Randomized Trial Evidence Using Egger Regression-Brief ReportChristopher Labos, James M Brophy, George Davey Smith, et al.
Pageof 25